Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Korea approves Opdivo-Yervoy for renal cell carcinoma treatment

biospectrumasiaSeptember 29, 2018

Tag: carcinoma , Cell , Opdivo-Yervoy

PharmaSources Customer Service